A18i builds and commercializes innovative oncology diagnostic assays by bridging scientific discovery with clinical application. They leverage deep scientific and healthcare industry expertise to accelerate the development and market launch of novel diagnostic technologies for cancer patients.
Funding
Funding not disclosed
Founders
Product
Problem
The development and commercialization of novel oncology diagnostic assays face significant hurdles, including the need for specialized scientific expertise, extensive healthcare industry knowledge, and robust go-to-market strategies. Bridging the gap between scientific discovery and clinical application often requires dedicated resources and strategic partnerships that many research institutions and early-stage ventures lack.
Solution
A18i operates as a venture builder focused on the oncology sector, specializing in the development and commercialization of innovative diagnostic assays. By integrating deep scientific understanding with comprehensive healthcare industry acumen, A18i identifies promising diagnostic technologies and cultivates them into market-ready solutions. The company fosters strategic collaborations with leading academic and research institutions to accelerate the translation of cutting-edge discoveries into clinical practice. This venture-building approach streamlines the assay development lifecycle, from initial concept validation through regulatory approval and market launch, ensuring that novel oncology diagnostics reach the patients who need them efficiently.
Target Audience
A18i targets academic research institutions, biotech startups, and pharmaceutical companies seeking to advance and commercialize novel oncology diagnostic technologies.
Features
- Venture building model specifically for oncology diagnostics
- Expertise in assay development, from concept to commercialization
- Strategic partnerships with leading research institutions
- Focus on translating scientific discoveries into clinical applications
- Deep understanding of the healthcare industry landscape